Daiwa Securities Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-498
| Closed | – | – | 1373 |
|
|
2023
Q3 | $0 | Hold |
498
| – | – | ﹤0.01% | 1325 |
|
|
2023
Q2 | $1K | Hold |
498
| – | – | ﹤0.01% | 1287 |
|
|
2023
Q1 | $1K | Hold |
498
| – | – | ﹤0.01% | 1271 |
|
|
2022
Q4 | $2K | Hold |
498
| – | – | ﹤0.01% | 1229 |
|
|
2022
Q3 | $2K | Hold |
498
| – | – | ﹤0.01% | 1239 |
|
|
2022
Q2 | $2K | Hold |
498
| – | – | ﹤0.01% | 1241 |
|
|
2022
Q1 | $3K | Hold |
498
| – | – | ﹤0.01% | 1222 |
|
|
2021
Q4 | $4K | Hold |
498
| – | – | ﹤0.01% | 1221 |
|
|
2021
Q3 | $4K | Buy |
498
+232
| +87% | +$1.86K | ﹤0.01% | 1195 |
|
|
2021
Q2 | $3K | Hold |
266
| – | – | ﹤0.01% | 1114 |
|
|
2021
Q1 | $3K | Hold |
266
| – | – | ﹤0.01% | 1117 |
|
|
2020
Q4 | $4K | Sell |
266
-536
| -67% | -$8.06K | ﹤0.01% | 1069 |
|
|
2020
Q3 | $8K | Buy |
802
+148
| +23% | +$1.48K | ﹤0.01% | 1050 |
|
|
2020
Q2 | $4K | Hold |
654
| – | – | ﹤0.01% | 1110 |
|
|
2020
Q1 | $4K | Hold |
654
| – | – | ﹤0.01% | 1111 |
|
|
2019
Q4 | $5K | Sell |
654
-72
| -10% | -$550 | ﹤0.01% | 1095 |
|
|
2019
Q3 | $7K | Hold |
726
| – | – | ﹤0.01% | 1043 |
|
|
2019
Q2 | $8K | Buy |
726
+77
| +12% | +$848 | ﹤0.01% | 1051 |
|
|
2019
Q1 | $6K | Buy |
649
+182
| +39% | +$1.68K | ﹤0.01% | 1057 |
|
|
2018
Q4 | $5K | Hold |
467
| – | – | ﹤0.01% | 1046 |
|
|
2018
Q3 | $8K | Hold |
467
| – | – | ﹤0.01% | 1043 |
|
|
2018
Q2 | $7K | Hold |
467
| – | – | ﹤0.01% | 1062 |
|
|
2018
Q1 | $9K | Buy |
+467
| New | +$9K | ﹤0.01% | 1027 |
|